NM 704 EXAM 1 | COMPLETE EXAM QUESTIONS WITH
CORRECT ANSWERS | ALREADY GRADED A+ | LATEST
EXAM 2025 | VERIFIED ANSWERS | JUST RELEASED
Advanced Nurse Practitioner Studies | Key Domains: Advanced Health Assessment & Diagnostic
Reasoning, Pathophysiology of Complex Disease Processes, Pharmacotherapeutics for Advanced
Practice, Evidence-Based Practice & Research Application, Professional Role Development & Ethics,
Health Policy & Advocacy, and Differential Diagnosis Formation | Expert-Aligned Structure |
Exam-Ready Format
Introduction
This structured NM 704 Exam 1 for 2025 provides 60 high-quality exam-style questions with
correct answers and rationales. It emphasizes the synthesis of advanced clinical knowledge,
application of diagnostic frameworks, selection of appropriate pharmacologic and
non-pharmacologic interventions, and the integration of evidence to support clinical
decision-making for the nurse practitioner student.
Answer Format
All correct answers appear in bold and cyan blue, accompanied by concise rationales explaining
the pathophysiological basis, the key diagnostic criterion, the first-line therapeutic choice with
justification, or the ethical/professional standard, and why alternative options are clinically
incorrect, suboptimal, or outside the advanced practice role.
1. A 62-year-old male presents with sudden-onset crushing substernal chest pain radiating
to the left arm, diaphoresis, and nausea. ECG shows ST-segment elevation in leads II, III, and
aVF. Which coronary artery is most likely occluded?
A. Left anterior descending (LAD)
B. Left circumflex (LCx)
C. Right coronary artery (RCA)
D. Left main coronary artery
Rationale: ST elevation in leads II, III, and aVF indicates an inferior myocardial infarction, typically
caused by occlusion of the right coronary artery (RCA), which supplies the inferior wall in ~85% of
individuals. LAD occlusion causes anterior MI (V1–V4); LCx causes lateral MI (I, aVL, V5–V6).
, 2. Which of the following is the first-line pharmacologic treatment for acute exacerbation of
systolic heart failure with volume overload?
A. Beta-blocker
B. ACE inhibitor
C. Loop diuretic
D. Calcium channel blocker
Rationale: Loop diuretics (e.g., furosemide) are first-line for symptomatic volume overload in acute
decompensated heart failure. ACE inhibitors and beta-blockers are foundational for chronic
management but not for acute relief of congestion. CCBs are generally avoided in systolic HF.
3. A 45-year-old woman with type 2 diabetes has an HbA1c of 9.2% despite metformin 2000
mg daily. According to current ADA guidelines, which agent is preferred as add-on therapy if
cardiovascular disease is present?
A. Sulfonylurea
B. DPP-4 inhibitor
C. GLP-1 receptor agonist
D. Thiazolidinedione
Rationale: ADA/EASD guidelines recommend GLP-1 RAs (e.g., semaglutide) or SGLT2 inhibitors as first
add-on in T2DM with established ASCVD, due to proven cardiovascular benefit. Sulfonylureas and TZDs
lack CV benefit and carry risks (hypoglycemia, weight gain, fractures).
4. Which finding is most consistent with primary adrenal insufficiency (Addison’s disease)?
A. Hypernatremia and hypokalemia
B. Hypoglycemia and hypertension
C. Hyponatremia, hyperkalemia, and hypotension
D. Hypercalcemia and weight gain
Rationale: Aldosterone deficiency in Addison’s leads to sodium loss (hyponatremia), potassium
retention (hyperkalemia), and volume depletion (hypotension). Hypoglycemia may occur due to
cortisol deficiency. Hypernatremia and hypertension are seen in hyperaldosteronism.
5. In evidence-based practice, the highest level of evidence for therapeutic interventions
comes from:
A. Expert opinion
B. Case series
C. Cohort studies
D. Systematic reviews of randomized controlled trials
Rationale: Systematic reviews/meta-analyses of RCTs (Level I evidence) provide the strongest support
for clinical decisions due to minimized bias and pooled statistical power. Expert opinion is Level
VII—the weakest.
6. A 70-year-old male presents with new-onset atrial fibrillation with rapid ventricular
response (HR 130 bpm). He is hemodynamically stable. What is the initial priority in
management?
A. Electrical cardioversion
B. Initiate amiodarone for rhythm control
C. Control ventricular rate
D. Start anticoagulation immediately
CORRECT ANSWERS | ALREADY GRADED A+ | LATEST
EXAM 2025 | VERIFIED ANSWERS | JUST RELEASED
Advanced Nurse Practitioner Studies | Key Domains: Advanced Health Assessment & Diagnostic
Reasoning, Pathophysiology of Complex Disease Processes, Pharmacotherapeutics for Advanced
Practice, Evidence-Based Practice & Research Application, Professional Role Development & Ethics,
Health Policy & Advocacy, and Differential Diagnosis Formation | Expert-Aligned Structure |
Exam-Ready Format
Introduction
This structured NM 704 Exam 1 for 2025 provides 60 high-quality exam-style questions with
correct answers and rationales. It emphasizes the synthesis of advanced clinical knowledge,
application of diagnostic frameworks, selection of appropriate pharmacologic and
non-pharmacologic interventions, and the integration of evidence to support clinical
decision-making for the nurse practitioner student.
Answer Format
All correct answers appear in bold and cyan blue, accompanied by concise rationales explaining
the pathophysiological basis, the key diagnostic criterion, the first-line therapeutic choice with
justification, or the ethical/professional standard, and why alternative options are clinically
incorrect, suboptimal, or outside the advanced practice role.
1. A 62-year-old male presents with sudden-onset crushing substernal chest pain radiating
to the left arm, diaphoresis, and nausea. ECG shows ST-segment elevation in leads II, III, and
aVF. Which coronary artery is most likely occluded?
A. Left anterior descending (LAD)
B. Left circumflex (LCx)
C. Right coronary artery (RCA)
D. Left main coronary artery
Rationale: ST elevation in leads II, III, and aVF indicates an inferior myocardial infarction, typically
caused by occlusion of the right coronary artery (RCA), which supplies the inferior wall in ~85% of
individuals. LAD occlusion causes anterior MI (V1–V4); LCx causes lateral MI (I, aVL, V5–V6).
, 2. Which of the following is the first-line pharmacologic treatment for acute exacerbation of
systolic heart failure with volume overload?
A. Beta-blocker
B. ACE inhibitor
C. Loop diuretic
D. Calcium channel blocker
Rationale: Loop diuretics (e.g., furosemide) are first-line for symptomatic volume overload in acute
decompensated heart failure. ACE inhibitors and beta-blockers are foundational for chronic
management but not for acute relief of congestion. CCBs are generally avoided in systolic HF.
3. A 45-year-old woman with type 2 diabetes has an HbA1c of 9.2% despite metformin 2000
mg daily. According to current ADA guidelines, which agent is preferred as add-on therapy if
cardiovascular disease is present?
A. Sulfonylurea
B. DPP-4 inhibitor
C. GLP-1 receptor agonist
D. Thiazolidinedione
Rationale: ADA/EASD guidelines recommend GLP-1 RAs (e.g., semaglutide) or SGLT2 inhibitors as first
add-on in T2DM with established ASCVD, due to proven cardiovascular benefit. Sulfonylureas and TZDs
lack CV benefit and carry risks (hypoglycemia, weight gain, fractures).
4. Which finding is most consistent with primary adrenal insufficiency (Addison’s disease)?
A. Hypernatremia and hypokalemia
B. Hypoglycemia and hypertension
C. Hyponatremia, hyperkalemia, and hypotension
D. Hypercalcemia and weight gain
Rationale: Aldosterone deficiency in Addison’s leads to sodium loss (hyponatremia), potassium
retention (hyperkalemia), and volume depletion (hypotension). Hypoglycemia may occur due to
cortisol deficiency. Hypernatremia and hypertension are seen in hyperaldosteronism.
5. In evidence-based practice, the highest level of evidence for therapeutic interventions
comes from:
A. Expert opinion
B. Case series
C. Cohort studies
D. Systematic reviews of randomized controlled trials
Rationale: Systematic reviews/meta-analyses of RCTs (Level I evidence) provide the strongest support
for clinical decisions due to minimized bias and pooled statistical power. Expert opinion is Level
VII—the weakest.
6. A 70-year-old male presents with new-onset atrial fibrillation with rapid ventricular
response (HR 130 bpm). He is hemodynamically stable. What is the initial priority in
management?
A. Electrical cardioversion
B. Initiate amiodarone for rhythm control
C. Control ventricular rate
D. Start anticoagulation immediately
